TY - JOUR A1 - Wolff, Martin A1 - Schüler, Anja A1 - Gast, Klaus A1 - Seckler, Robert A1 - Evers, Andreas A1 - Pfeiffer-Marek, Stefania A1 - Kurz, Michael A1 - Nagel, Norbert A1 - Haack, Torsten A1 - Wagner, Michael A1 - Thalhammer, Anja T1 - Self-Assembly of Exendin-4-Derived Dual Peptide Agonists is Mediated by Acylation and Correlated to the Length of Conjugated Fatty Acyl Chains JF - Molecular pharmaceutics N2 - Dual glucagon-like peptide-1/glucagon receptor agonists have emerged as promising candidates for the treatment of diabetes and obesity. Issues of degradation sensitivity and rapid renal clearance are addressed, for example, by the conjugation of peptides to fatty acid chains, promoting reversible albumin binding. We use combined dynamic and static light scattering to directly measure the self-assembly of a set of dual peptide agonists based on the exendin-4 structure with varying fatty acid chain lengths in terms of apparent molecular mass and hydrodynamic radius (R-S). We use NMR spectroscopy to gain an insight into the molecular architecture of the assembly. We investigate conformational changes of the monomeric subunits resulting from peptide self-assembly and assembly stability as a function of the fatty acid chain length using circular dichroism and fluorescence spectroscopy. Our results demonstrate that self-assembly of the exendin-4-derived dual agonist peptides is essentially driven by hydrophobic interactions involving the conjugated acyl chains. The fatty acid chain length affects assembly equilibria and the assembly stability, although the peptide subunits in the assembly retain a dynamic secondary structure. The assembly architecture is characterized by juxtaposition of the fatty acyl side chains and a hydrophobic cluster of the peptide moiety. This cluster experiences local conformational changes in the assembly compared to the monomeric unit leading to a reduction in solvent exposure. The N-terminal half of the peptide and a C-terminal loop are not in contact with neighboring peptide subunits in the assemblies. Altogether, our study contributes to a thorough understanding of the association characteristics and the tendency toward self-assembly in response to lipidation. This is important not only to achieve the desired bioavailability but also with respect to the physical stability of peptide solutions. KW - dual GLP-1/glucagon receptor agonist KW - self-assembly KW - light scattering KW - molecular architecture KW - lipidation KW - exendin-4 Y1 - 2020 U6 - https://doi.org/10.1021/acs.molpharmaceut.9b01195 SN - 1543-8384 VL - 17 IS - 3 SP - 965 EP - 978 PB - American Chemical Society CY - Washington ER - TY - JOUR A1 - Wolff, Martin A1 - Schüler, Anja A1 - Gast, Klaus A1 - Seckler, Robert A1 - Evers, Andreas A1 - Pfeiffer-Marek, Stefania A1 - Kurz, Michael A1 - Nagel, Norbert A1 - Haack, Torsten A1 - Wagner, Michael A1 - Thalhammer, Anja T1 - Self-Assembly of Exendin-4-Derived Dual Peptide Agonists is Mediated by Acylation and Correlated to the Length of Conjugated Fatty Acyl Chains JF - Molecular pharmaceutics N2 - Dual glucagon-like peptide-1/glucagon receptor agonists have emerged as promising candidates for the treatment of diabetes and obesity. Issues of degradation sensitivity and rapid renal clearance are addressed, for example, by the conjugation of peptides to fatty acid chains, promoting reversible albumin binding. We use combined dynamic and static light scattering to directly measure the self-assembly of a set of dual peptide agonists based on the exendin-4 structure with varying fatty acid chain lengths in terms of apparent molecular mass and hydrodynamic radius (R-S). We use NMR spectroscopy to gain an insight into the molecular architecture of the assembly. We investigate conformational changes of the monomeric subunits resulting from peptide self-assembly and assembly stability as a function of the fatty acid chain length using circular dichroism and fluorescence spectroscopy. Our results demonstrate that self-assembly of the exendin-4-derived dual agonist peptides is essentially driven by hydrophobic interactions involving the conjugated acyl chains. The fatty acid chain length affects assembly equilibria and the assembly stability, although the peptide subunits in the assembly retain a dynamic secondary structure. The assembly architecture is characterized by juxtaposition of the fatty acyl side chains and a hydrophobic cluster of the peptide moiety. This cluster experiences local conformational changes in the assembly compared to the monomeric unit leading to a reduction in solvent exposure. The N-terminal half of the peptide and a C-terminal loop are not in contact with neighboring peptide subunits in the assemblies. Altogether, our study contributes to a thorough understanding of the association characteristics and the tendency toward self-assembly in response to lipidation. This is important not only to achieve the desired bioavailability but also with respect to the physical stability of peptide solutions. KW - dual GLP-1/glucagon receptor agonist KW - self-assembly KW - light scattering KW - molecular architecture KW - lipidation KW - exendin-4 Y1 - 2020 U6 - https://doi.org/10.1021/acs.molpharmaceut.9b01195 SN - 1543-8384 SN - 1543-8392 VL - 17 IS - 3 SP - 965 EP - 978 PB - American Chemical Society CY - Washington ER - TY - JOUR A1 - Gast, Klaus A1 - Schüler, Anja A1 - Wolff, Martin A1 - Thalhammer, Anja A1 - Berchtold, Harald A1 - Nagel, Norbert A1 - Lenherr, Gudrun A1 - Hauck, Gerrit A1 - Seckler, Robert T1 - Rapid-acting and human insulins BT - Hexamer Dissociation Kinetics upon Dilution of the Pharmaceutical Formulation JF - Pharmaceutical research N2 - Comparison of the dissociation kinetics of rapid-acting insulins lispro, aspart, glulisine and human insulin under physiologically relevant conditions. Dissociation kinetics after dilution were monitored directly in terms of the average molecular mass using combined static and dynamic light scattering. Changes in tertiary structure were detected by near-UV circular dichroism. Glulisine forms compact hexamers in formulation even in the absence of Zn2+. Upon severe dilution, these rapidly dissociate into monomers in less than 10 s. In contrast, in formulations of lispro and aspart, the presence of Zn2+ and phenolic compounds is essential for formation of compact R6 hexamers. These slowly dissociate in times ranging from seconds to one hour depending on the concentration of phenolic additives. The disadvantage of the long dissociation times of lispro and aspart can be diminished by a rapid depletion of the concentration of phenolic additives independent of the insulin dilution. This is especially important in conditions similar to those after subcutaneous injection, where only minor dilution of the insulins occurs. Knowledge of the diverging dissociation mechanisms of lispro and aspart compared to glulisine will be helpful for optimizing formulation conditions of rapid-acting insulins. KW - circular dichroism KW - dissociation kinetics KW - insulin analog KW - light scattering KW - rapid-acting Y1 - 2017 U6 - https://doi.org/10.1007/s11095-017-2233-0 SN - 0724-8741 SN - 1573-904X VL - 34 IS - 795 SP - 2270 EP - 2286 PB - Springer CY - New York ER - TY - GEN A1 - Gast, Klaus A1 - Schüler, Anja A1 - Wolff, Martin A1 - Thalhammer, Anja A1 - Berchtold, Harald A1 - Nagel, Norbert A1 - Lenherr, Gudrun A1 - Hauck, Gerrit A1 - Seckler, Robert T1 - Rapid-acting and human insulins BT - hexamer dissociation kinetics upon dilution of the pharmaceutical formulation T2 - Postprints der Universität Potsdam Mathematisch-Naturwissenschaftliche Reihe N2 - Purpose: Comparison of the dissociation kinetics of rapid-acting insulins lispro, aspart, glulisine and human insulin under physiologically relevant conditions. Methods: Dissociation kinetics after dilution were monitored directly in terms of the average molecular mass using combined static and dynamic light scattering. Changes in tertiary structure were detected by near-UV circular dichroism. Results: Glulisine forms compact hexamers in formulation even in the absence of Zn2+. Upon severe dilution, these rapidly dissociate into monomers in less than 10 s. In contrast, in formulations of lispro and aspart, the presence of Zn2+ and phenolic compounds is essential for formation of compact R6 hexamers. These slowly dissociate in times ranging from seconds to one hour depending on the concentration of phenolic additives. The disadvantage of the long dissociation times of lispro and aspart can be diminished by a rapid depletion of the concentration of phenolic additives independent of the insulin dilution. This is especially important in conditions similar to those after subcutaneous injection, where only minor dilution of the insulins occurs. Conclusion: Knowledge of the diverging dissociation mechanisms of lispro and aspart compared to glulisine will be helpful for optimizing formulation conditions of rapid-acting insulins. T3 - Zweitveröffentlichungen der Universität Potsdam : Mathematisch-Naturwissenschaftliche Reihe - 795 KW - circular dichroism KW - dissociation kinetics KW - insulin analog KW - light scattering KW - rapid-acting Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus4-431572 SN - 1866-8372 IS - 795 SP - 2270 EP - 2286 ER -